Hostname: page-component-8448b6f56d-gtxcr Total loading time: 0 Render date: 2024-04-24T22:07:54.858Z Has data issue: false hasContentIssue false
  • English
  • Français

Definitional Change in NHSN CAUTI Was Associated with an Increase in CLABSI Events: Evaluation of a Large Health System

Published online by Cambridge University Press:  23 March 2017

Mohamad G. Fakih ,
Clariecia Groves ,
Angelo Bufalino ,
Lisa K. Sturm  and
Ann L. Hendrich
Mohamad G. Fakih*
Affiliation:
Care Excellence, Ascension Health, St. Louis, Missouri
Clariecia Groves
Affiliation:
Care Excellence, Ascension Health, St. Louis, Missouri
Angelo Bufalino
Affiliation:
Care Excellence, Ascension Health, St. Louis, Missouri
Lisa K. Sturm
Affiliation:
Care Excellence, Ascension Health, St. Louis, Missouri
Ann L. Hendrich
Affiliation:
Care Excellence, Ascension Health, St. Louis, Missouri
*
Address correspondence to Mohamad G. Fakih, MD, MPH, Senior Medical Director, Ascension Center of Excellence for Antimicrobial Stewardship and Infection Prevention, 19251 Mack Ave, Suite 190, Grosse Pointe Woods, MI 48236 (Mohamad.Fakih@ascension.org).
Get access Rights & Permissions [Opens in a new window]

Abstract

BACKGROUND

The National Healthcare Safety Network (NHSN) catheter-associated urinary tract infection (CAUTI) definition was revised as of January 2015 to exclude funguria and lower bacteriuria levels. We evaluated the effect of the CAUTI definition change on NHSN-defined central-line–associated bloodstream infection (CLABSI) outcomes.

METHODS

We compared CAUTI and CLABSI NHSN-defined outcomes for calendar years 2014 and 2015 in the adult intensive care units (ICUs) of a single large health system. Changes in the event rates, the associated organisms, and the standardized infection ratio (SIR) were evaluated.

RESULTS

The study included 137 adult ICUs from 65 hospitals. The CAUTI SIR dropped from 1.04 in 2014 to 0.58 in 2015 (−44.2%), while the CLABSI SIR increased from 0.36 in 2014 to 0.47 in 2015 (+30.6%). CAUTI rates dropped 44.8% from 2.09 to 1.15 events per 1,000 device days (P<.001). Gram-positive–associated CAUTI rates dropped 36.7% from 0.34 to 0.22 per 1,000 device days (P=.007). CLABSI rates increased 27.1% from 0.71 to 0.90 per 1,000 device days (P=.027). Candida-associated CLABSI increased by 91.1% from 0.104 to 0.198 per 1,000 device days (P=.012), and Enterococcus-associated CLABSI increased by 121.6% from 0.071 to 0.16 per 1,000 device days (P=.008).

CONCLUSIONS

The revised CAUTI definition led to a large reduction in CAUTI rates and, in turn, an increase in candidemia and enterococcemia cases classified as CLABSI events. These findings have important implications on the perceived successes or failures to eliminate both infections.

Infect Control Hosp Epidemiol 2017;38:685–689

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 38 , Issue 6 , June 2017 , pp. 685 - 689
Copyright
© 2017 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATION: These data were presented on May 18, 2016, at the SHEA Spring 2016 conference in Atlanta, Georgia (Abstract #520). This abstract was selected as 1 of 23 outstanding abstracts for the SHEA Top Poster Abstract Award.

References

REFERENCES

1. Umscheid, CA, Mitchell, MD, Doshi, JA, Agarwal, R, Williams, K, Brennan, PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol 2011;32:101–114.Google Scholar
2. Medicare program: changes to the hospital inpatient prospective payment systems and fiscal year 2009 rates; payments for graduate medical education in certain emergency situations; changes to disclosure of physician ownership in hospitals and physician self-referral rules; updates to the long-term care prospective payment system; updates to certain IPPS-excluded hospitals; and collection of information regarding financial relationships between hospitals. Final rules. Fed Regist 2008;73:48433–49084.Google Scholar
3. Centers for Disease Control and Prevention. National Healthcare Safety Network. Surveillance for Urinary Tract infections. Centers for Disease Control and Prevention website. http://www.cdc.gov/nhsn/acute-care-hospital/CAUTI/index.html. Published 2015. Accessed November 14, 2016.Google Scholar
4. Centers for Disease Control and Prevention. National Healthcare Safety Network. Surveillance for Bloodstream Infections. Centers for Disease Control and Prevention website. http://www.cdc.gov/nhsn/acute-care-hospital/clabsi/. Published 2015. Accessed November 14, 2016.Google Scholar
5. Fakih, MG, Gould, CV, Trautner, BW, et al. Beyond infection: device utilization ratio as a performance measure for urinary catheter harm. Infect Control Hosp Epidemiol 2016;37:327–333.Google Scholar
6. Centers for Disease Control and Prevention. NHSN Newsletter September 2014. NHSN e-news 2014;9:1–23. http://www.cdc.gov/nhsn/newsletters/. Updated 2016. Accessed November 20, 2016.Google Scholar
7. Mullin, KM, Kovacs, CS, Fatica, C, et al. A multifaceted approach to reduction of catheter-associated urinary tract infections in the intensive care unit with an emphasis on “stewardship of culturing”. Infect Control Hosp Epidemiol 2017;38:186–188.Google Scholar
8. Trautner, BW, Grigoryan, L, Petersen, NJ, et al. Effectiveness of an antimicrobial stewardship approach for urinary catheter–associated asymptomatic bacteriuria. JAMA Intern Med 2015;175:1120–1127.Google Scholar
9. Dudeck, MA, Edwards, JR, Allen-Bridson, K, et al. National Healthcare Safety Network report, data summary for 2013, device-associated module. Am J Infect Control 2015;43:206–221.Google Scholar
10. Tedja, R, Wentink, J, O’Horo, JC, Thompson, R, Sampathkumar, P. Catheter-associated urinary tract infections in intensive care unit patients. Infect Control Hosp Epidemiol 2015;36:1330–1334.Google Scholar
11. Cope, M, Cevallos, ME, Cadle, RM, Darouiche, RO, Musher, DM, Trautner, BW. Inappropriate treatment of catheter-associated asymptomatic bacteriuria in a tertiary care hospital. Clin Infect Dis 2009;48:1182–1188.Google Scholar
12. Garibaldi, RA, Mooney, BR, Epstein, BJ, Britt, MR. An evaluation of daily bacteriologic monitoring to identify preventable episodes of catheter-associated urinary tract infection. Infect Control 1982;3:466–470.Google Scholar
13. Tambyah, PA, Maki, DG. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. Arch Intern Med 2000;160:678–682.Google Scholar
14. Greene, MT, Ratz, D, Meddings, J, Fakih, MG, Saint, S. Potential misclassification of urinary tract–related bacteremia upon applying the 2015 catheter-associated urinary tract infection surveillance definition from the National Healthcare Safety Network. Infect Control Hosp Epidemiol 2016;37:469–471.CrossRefGoogle ScholarPubMed
15. Centers for Disease Control and Prevention (CDC). Vital signs: carbapenem-resistant Enterobacteriaceae. Morb Mortal Wkly Rep 2013;62:165–170.Google Scholar
16. Sievert, DM, Ricks, P, Edwards, JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol 2013;34:1–14.Google Scholar
17. Drekonja, DM, Rector, TS, Cutting, A, Johnson, JR. Urinary tract infection in male veterans: treatment patterns and outcomes. Arch Intern Med 2013;173:62–68.Google Scholar
18. Al-Qas Hanna, F, Sambirska, O, Iyer, S, Szpunar, S, Fakih, MG. Clinician practice and the National Healthcare Safety Network definition for the diagnosis of catheter-associated urinary tract infection. Am J Infect Control 2013;41:1173–1177.Google Scholar
19. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and Fiscal Year 2014 rates; quality reporting requirements for specific providers; hospital conditions of participation; payment policies related to patient status. Final rules. Fed Regist 2013;78:50495–51040.Google Scholar
20. Centers for Medicare & Medicaid Services (CMS). Hospital-Acquired Conditions Reduction Program (HACRP). https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/HAC-Reduction-Program.html. Updated 2016. Accessed November 12, 2016.Google Scholar
21. Halpin, AL, Sinkowitz-Cochran, R, Allen-Bridson, K, et al. Letter in response to “Questionable validity of the catheter-associated urinary tract infection metric used for value-based purchasing. Am J Infect Control 2016;44:369–370.Google Scholar
22. Rock, C, Thom, KA, Harris, AD, et al. A multicenter longitudinal study of hospital-onset bacteremia: time for a new quality outcome measure? Infect Control Hosp Epidemiol 2016;37:143–148.Google Scholar